Singaporean startup Mesh Bio has received undisclosed funding from East Ventures to assist with its regional expansion.
The company is currently working on a digital twin solution for managing rising cases of chronic diseases, particularly in Southeast Asia, where 62% of all deaths in the region are due to non-communicable conditions. Mesh Bio's DARA health intelligence platform provides multidimensional patient data in near real-time. It also delivers predictive analytics to identify patients at risk of chronic diseases.
Its fresh funding will help further develop its digital twin engine, as well as expand its services across Southeast Asia, mainly in Indonesia, Malaysia, and the Philippines.
Source: Mobi Health News